QSC Research Grade · Shop at qscpeptide.com →

Collagen & Aging

Longevity science · How this pathway drives aging · How Midas addresses it

Collagen makes up 75% of skin dry weight and is the primary structural protein in joints, bones, tendons, and blood vessels. Production declines ~1% per year starting in the mid-20s, accelerating dramatically post-menopause (women lose ~30% of skin collagen in the first 5 years). By 60, most adults have lost 50%+ of their youthful collagen. GHK-Cu addresses this directly by activating collagen I, III, and IV synthesis, elastin production, and glycosaminoglycan (GAG) formation. Research at the Broad Institute showed GHK-Cu modulates ~4,000 human genes, essentially resetting gene expression to a more youthful pattern. Clinical studies show 70% response rate for measurable collagen increases.

The Midas Approach

The Midas Longevity Protocol doesn't address collagen & aging in isolation — it targets this pathway alongside 9 other aging mechanisms simultaneously. This multi-pathway approach reflects the scientific consensus that aging is not a single process but a network of interconnected pathways (Lopez-Otin et al., Cell 2023, "Hallmarks of Aging").

Learn more: 12 Hallmarks of Aging & How Midas Maps to Each

Shop the Midas Longevity Protocol

12 compounds. 10 longevity pathways. 120 vials. ≥99% purity. Janoshik COA.

Buy at QSC →
The Protocol 12 Compounds Where to Buy FAQ Shop Now →

QSC Network

Shop QSC Compound Guides Ascension Stack Venus Protocol EU Warehouse

QSC Longevity Network

Research Use Only. All products are for laboratory research only. Not for human consumption. No medical claims. Supplied by QSC (qscpeptide.com). ≥99% HPLC purity, Janoshik COA.